Indegene IPO Proceeds: Monitoring Agency Reports NIL Deviation

Indegene Ltd. has submitted the Monitoring Agency Report for the quarter ended March 31, 2026, as mandated by SEBI regulations. The report, issued by CARE Ratings Limited (Care Edge Ratings), monitors the utilization of proceeds from the company's Initial Public Offering (IPO) of ₹760.00 crores. The report confirms "NIL" deviation from the objects disclosed in the Offer Document and states that all utilization is as per the disclosures. The company also confirmed that shareholder approval was obtained in case of any material deviations, though none were reported.